Farnesyltransferase as a target for anticancer drug design
- 1 January 1997
- journal article
- review article
- Published by Wiley in Biopolymers
- Vol. 43 (1) , 25-41
- https://doi.org/10.1002/(sici)1097-0282(1997)43:1<25::aid-bip4>3.0.co;2-2
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- On the Stereochemical Course of Human Protein-Farnesyl TransferaseJournal of the American Chemical Society, 1996
- Local constrained shifty pseudopeptides inhibitors of rasfarnesyl transferaseBioorganic & Medicinal Chemistry Letters, 1995
- CAAX Peptidomimetic FTI-244 Decreases Platelet-Derived Growth Factor Receptor Tyrosine Phosphorylation Levels and Inhibits Stimulation of Phosphatidylinositol 3-Kinase but Not Mitogen-Activated Protein KinaseBiochemical and Biophysical Research Communications, 1995
- Constrained analogs of KCVFM with improved inhibitory properties against farnesyl transferaseBioorganic & Medicinal Chemistry Letters, 1995
- Crystal Structure of the Mammalian Grb2 AdaptorScience, 1995
- Quantitative Analysis of the Complex between p21 and the Ras-binding Domain of the Human Raf-1 Protein KinaseJournal of Biological Chemistry, 1995
- Phenol based tripeptide inhibitors of ras farnesyl protein transferaseBioorganic & Medicinal Chemistry Letters, 1994
- Purification of ras farnesyl:Protein transferaseMethods, 1990
- Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistryCell, 1980
- An Unidentified Virus which causes the Rapid Production of Tumours in MiceNature, 1964